Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
US Stock Market Move | "Encrypted whale Strategy (MSTR.US) continues to fall by over 3%, selling 32 bitcoins causing market panic."
"Funds 'buying on the dip' drive Vanguard S&P 500 ETF (VOO.US) assets surpassing one trillion US dollars, setting an industry record."
US Stock Market Move | Many popular Chinese concept stocks mostly fell. Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) dropped nearly 6%. UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) dropped nearly 5%.
US Stock Market Move | "Encrypted whale Strategy (MSTR.US) continues to fall by over 3%, selling 32 bitcoins causing market panic."
"Funds 'buying on the dip' drive Vanguard S&P 500 ETF (VOO.US) assets surpassing one trillion US dollars, setting an industry record."
US Stock Market Move | Many popular Chinese concept stocks mostly fell. Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) dropped nearly 6%. UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) dropped nearly 5%.
